Xeris Pharmaceuticals, Inc.
Chicago, United States
396 employees
Post Ipo Debt
Total: $548.50M
Biotechnology, Health Care +2
General Information
Get notified when Xeris Pharmaceuticals, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Xeris Pharmaceuticals, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Xeris Pharmaceuticals, Inc.
Taxonomy: biopharmaceutical company, novel formulation technology, drug delivery, specialty pharmaceuticals, injectables, subcutaneous delivery, intramuscular delivery, peptides, proteins, antibodies, small molecules, ready-to-use formulations, room temperature stability
Funding Rounds & Investors (14)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | 1 | •••• •••• | 06 Mar 2024 |
| Post-IPO Equity | •••••• | 1 | •••• •••• | 03 Jan 2022 |
| Post-IPO Equity | •••••• | 1 | •••• •••• | 11 Mar 2021 |
| Post-IPO Debt | •••••• | 2 | •••• •••• | 10 Sep 2019 |
| Post-IPO Equity | •••••• | - | 13 Feb 2019 |
Xeris Pharmaceuticals, Inc. Alternatives & Competitors
Meet the "Uber" for all last-mile deliveries. Dorado offers on-demand delivery of everything you n...
-logo.jpg "투데이(vtov)"){kind=logo}
JHC Courier provides reliable and quick delivery locally, nationally, and internationally with guara...
FAQ About Xeris Pharmaceuticals, Inc.
Don't just browse. Track.
Signal Tracker monitors Xeris Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
